When was H.C. Wainwright founded?

H.C. Wainwright was founded in 1868.

Where is H.C. Wainwright's headquarters located?

H.C. Wainwright's headquarters is located in New York City (United States).

How big is H.C. Wainwright's team?

H.C. Wainwright has a team of 71, including 18 partners.

What types of deals does H.C. Wainwright primarily facilitate?

H.C. Wainwright primarily facilitates Post IPO, Business Acquisition deals for United States, Canada based companies.

What sectors does H.C. Wainwright facilitate deals in?

H.C. Wainwright facilitates deals across a wide range of sectors from Life Sciences to High Tech.

How many companies has H.C. Wainwright invested in?

H.C. Wainwright has invested in 6 companies.

H.C. Wainwright - 2026 Investment Bank Profile, Deals and M&A

Most viewed in 2019

H.C. Wainwright is an investment bank founded in 1868. It is primarily based in New York City, United States. As of Nov 2026, H.C. Wainwright has facilitated 192 deals, comprising 13 M&A deals and 179 funding rounds. It has facilitated 11 deals in the last 12 months. It primarily facilitates Post IPO and Business Acquisition deals for United States and Canada based companies. The deals facilitated are spread across a wide range of sectors from Life Sciences to High Tech. Most recently, it facilitated the $***** Post IPO round of MysizeID on Sep 15, 2026 and the acquisition of XOMA Corporation by Ligand Pharmaceuticals on Jul 14, 2026. Apart from facilitating deals, H.C. Wainwright has also invested in 6 companies.

Key Metrics

Founded Year

1868

Location

New York City, United States

No. of Deals facilitated

192

No. of Deals facilitated in last 12 months

Top Deal Types

Post IPO, Business Acquisition

Top Locations of Deals

United States, Canada

Top Sectors of Deals

Life Sciences, High Tech

Funding Rounds Facilitated

MysizeID, Enveric & 177 more

M&A Facilitated

XOMA Corporation, Lisata & 11 more

View H.C. Wainwright's full profile

H.C. Wainwright has facilitated a total of 179 funding deals including Post IPO deals. The latest round that they facilitated was on Sep 15, 2026 for MysizeID in their Post IPO round of $*****.Their most notable funding round deals include a $***** Post IPO round of Ligand Pharmaceuticals.

Here is the list of recent funding rounds facilitated by H.C. Wainwright:

Date	Company	Round Name	Amount	Investors
Sep 15, 2026	MysizeID	Post IPO	6354	-
Apr 17, 2026	Enveric	Post IPO	1824	-
Mar 27, 2026	Artelo Biosciences	Post IPO	5482	-
Mar 23, 2026	TEMPEST THERAPEUTICS	Post IPO	6617	-

View all Funding Deals facilitated by H.C. Wainwright

The latest M&A that they facilitated was on Jul 14, 2026 where XOMA Corporation was acquired by Ligand Pharmaceuticals.Their most notable M&A deals include acquisition of Tangent Labs by Transcat.

Here is the list of recent M&A deals facilitated by H.C. Wainwright:

Date	Company	Amount	Acquirers	Co Facilitators
Jul 14, 2026	XOMA Corporation	1565	Ligand Pharmaceuticals	Leerink Partners and 3 more
Jan 21, 2026	Lisata	3015	Kuva Labs	Mintz and 1 more
Aug 26, 2024	Agile Therapeutics	1399	Insud Pharma	Loeb & Loeb and 2 more
Apr 25, 2023	Spectrum Pharmaceuticals	2693	Assertio	Guggenheim Partners and 4 more

View all Acquisition Deals facilitated by H.C. Wainwright

H.C. Wainwright has a team of 71 members including 18 Partners and 16 Principals located in United States. H.C. Wainwright's team does not sit on the board of any company as of now.

Here is a list of top team members in H.C. Wainwright:

Name	Designation	Location	Contact Details
Norman Yun	Partner	New York City	-
Joseph Pantginis	Partner	New York City	-
Yi Chen	Partner	New York City	-
Andrew Fein	Partner	New York City	-
Heiko Ihle	Partner	White Plains	-
Jason Kolbert	Partner	United States	1 Email
Oren G Livnat	Partner	New York City	-
Russ Steward	Partner	New York City	-
Mike Colonnese	Partner	New York City	-
Amit Dayal	Partner	New York City	-
Patrick R Trucchio	Partner	New York City	-